Guangxi Liuzhou Pharm Co Ltd Net Asset Momentum
Guangxi Liuzhou Pharm Co Ltd net asset momentum. Guangxi Liuzhou Pharm Co Ltd (603368) recorded a net asset momentum of 12.4% as of December 2024, with net assets of CN¥7.94 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 603368 total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Net asset momentum of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. This chart tracks Guangxi Liuzhou Pharm Co Ltd's year-over-year net asset growth across 14 annual reporting periods from 2011 to 2024. The most recent momentum reading is +12.4%, with net assets of CN¥7.94 Billion CNY as of December 2024. Check 603368 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Guangxi Liuzhou Pharm Co Ltd Net Asset Momentum by Year (2011–2024)
Guangxi Liuzhou Pharm Co Ltd net asset momentum by year from 2011 to 2024. The table below shows the complete annual net asset history for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 603368 stock market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥7.94 Billion | CN¥21.27 Billion | CN¥13.33 Billion | ▲ +12.4% |
| 2023 | CN¥7.06 Billion | CN¥20.16 Billion | CN¥13.10 Billion | ▲ +11.0% |
| 2022 | CN¥6.37 Billion | CN¥18.61 Billion | CN¥12.24 Billion | ▲ +9.6% |
| 2021 | CN¥5.81 Billion | CN¥15.87 Billion | CN¥10.07 Billion | ▲ +6.6% |
| 2020 | CN¥5.44 Billion | CN¥14.81 Billion | CN¥9.36 Billion | ▲ +16.9% |
| 2019 | CN¥4.66 Billion | CN¥11.96 Billion | CN¥7.30 Billion | ▲ +15.1% |
| 2018 | CN¥4.05 Billion | CN¥9.77 Billion | CN¥5.73 Billion | ▲ +13.4% |
| 2017 | CN¥3.57 Billion | CN¥7.55 Billion | CN¥3.99 Billion | ▲ +10.2% |
| 2016 | CN¥3.24 Billion | CN¥6.28 Billion | CN¥3.04 Billion | ▲ +138.0% |
| 2015 | CN¥1.36 Billion | CN¥4.30 Billion | CN¥2.94 Billion | ▲ +15.9% |
| 2014 | CN¥1.17 Billion | CN¥3.74 Billion | CN¥2.56 Billion | ▲ +134.3% |
| 2013 | CN¥501.00 Million | CN¥2.70 Billion | CN¥2.20 Billion | ▲ +32.3% |
| 2012 | CN¥378.59 Million | CN¥2.03 Billion | CN¥1.65 Billion | ▲ +38.1% |
| 2011 | CN¥274.23 Million | CN¥1.57 Billion | CN¥1.30 Billion | — |